Iodine-131

protein tyrosine phosphatase receptor type C ; Homo sapiens







12 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 31481510 Phase I Study of a CD45-Targeted Antibody-Radionuclide Conjugate for High-Risk Lymphoma. 2019 Dec 1 1
2 26137289 Predictive factors of cytotoxic damage in radioactive iodine treatment of differentiated thyroid cancer patients. 2015 May 1
3 24858425 Radiolabeled anti-CD45 antibody with reduced-intensity conditioning and allogeneic transplantation for younger patients with advanced acute myeloid leukemia or myelodysplastic syndrome. 2014 Sep 1
4 19332764 131I anti-CD45 radioimmunotherapy effectively targets and treats T-cell non-Hodgkin lymphoma. 2009 Jun 4 1
5 19786617 Allogeneic hematopoietic cell transplantation after conditioning with 131I-anti-CD45 antibody plus fludarabine and low-dose total body irradiation for elderly patients with advanced acute myeloid leukemia or high-risk myelodysplastic syndrome. 2009 Dec 24 1
6 16254140 131I-anti-CD45 antibody plus busulfan and cyclophosphamide before allogeneic hematopoietic cell transplantation for treatment of acute myeloid leukemia in first remission. 2006 Mar 1 1
7 11461662 The development of monoclonal antibody therapy in leukemias. 2001 Jun 1
8 10687726 Clinical studies of new "biologic" approaches to therapy of acute myeloid leukemia with monoclonal antibodies and immunoconjugates. 2000 Jan 1
9 10950142 Targeted therapy of acute myeloid leukemia with monoclonal antibodies and immunoconjugates. 2000 1
10 10530710 Antibody-targeted therapy for myeloid leukemia. 1999 Oct 1
11 7849300 Development of a marrow transplant regimen for acute leukemia using targeted hematopoietic irradiation delivered by 131I-labeled anti-CD45 antibody, combined with cyclophosphamide and total body irradiation. 1995 Feb 15 2
12 1832994 Radiolabeled anti-CD45 monoclonal antibodies target lymphohematopoietic tissue in the macaque. 1991 Oct 1 1